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Abstract The AMPA-type ionotropic glutamate receptors
(AMPA-Rs) are tetrameric ligand-gated ion channels that
play crucial roles in synaptic transmission and plasticity.
Our knowledge about the ultrastructure and subunit
assembly mechanisms of intact AMPA-Rs was very limited.
However, the new studies using single particle EM and
X-ray crystallography are revealing important insights. For
example, the tetrameric crystal structure of the GluA2cryst
construct provided the atomic view of the intact receptor. In
addition, the single particle EM structures of the subunit
assembly intermediates revealed the conformational
requirement for the dimer-to-tetramer transition during the
maturation of AMPA-Rs. These new data in the field
provide new models and interpretations. In the brain, the
native AMPA-R complexes contain auxiliary subunits that
influence subunit assembly, gating, and trafficking of the
AMPA-Rs. Understanding the mechanisms of the auxiliary
subunits will become increasingly important to precisely
describe the function of AMPA-Rs in the brain. The
AMPA-R proteomics studies continuously reveal a previ-
ously unexpected degree of molecular heterogeneity of the
complex. Because the AMPA-Rs are important drug targets
for treating various neurological and psychiatric diseases, it
is likely that these new native complexes will require
detailed mechanistic analysis in the future. The current
ultrastructural data on the receptors and the receptor-
expressing stable cell lines that were developed during the
course of these studies are useful resources for high
throughput drug screening and further drug designing.
Moreover, we are getting closer to understanding the precise
mechanisms of AMPA-R-mediated synaptic plasticity.
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Introduction
The majority of fast excitatory synaptic transmission in the
brain is mediated by AMPA (α-amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid) receptors (AMPA-Rs), a subset
of ligand-gated ion channels of the glutamate receptor
family [1, 2]. The function of AMPA-Rs is critical for
synaptic plasticity. Their dysfunction relates to various
neurological and psychiatric disorders. The diseases that are
affected by AMPA-Rs include X-linked mental retardation,
Alzheimer’s disease, amyotrophic lateral sclerosis, limbic
encephalitis, ischemic brain injury, and Rasmussen’s
encephalitis [3–14]. The ultrastructure, conformational
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bly mechanisms, trafficking, and localization are character-
istics that define the function of AMPA-Rs. The precise
understanding of the biophysical and cell biological
properties of AMPA-Rs will reveal some of the important
mechanisms of synaptic plasticity and assists in identifying
therapeutic measures to the diseases affected by AMPA-Rs.
The Primary Structure of the AMPA-R Subunits
From 1989 to 1992, the genes that encode the glutamate
receptor subunits were discovered and reported [15–21].
Recent publications in the field use the GluA1–4 nomen-
clatures to refer to the four AMPA-R subunits [22]. The
protein products of the four AMPA-R subunits share
homology and domain organization. Each subunit of
AMPA-Rs consists of four major domains (Fig. 1a, b).
The amino terminus is located in the extracellular space and
forms the N-terminal domain (NTD) consisting of about
370 amino acids. The NTDs of glutamate receptors are
homologous to the bacterial amino acid binding protein
LIVBP and the ligand binding domains of the metabotropic
glutamate receptors, also known as mGluRs [23, 24]. The
NTD is followed by a linker sequence and connects to
another extracellular domain, the ligand binding domain
(LBD). The linker connection between the NTD and the
LBD is made of about 17 amino acids. The primary
structure of the LBD, made of about 270 amino acids, is
subdivided into two separated sub-fragments denoted as S1
and S2 [25]. The LBD undergoes conformational changes
resulting in channel gating upon glutamate binding. The
polypeptide chain forming the LBD is interrupted between
the S1 and S2 fragments by two membrane spanning
segments (M1 and M3) and one re-entrant loop (M2). The
fourth membrane spanning segment (M4) is located at the
C-terminal end of the S2 fragment. The channel pore-
forming transmembrane domain (TMD) consists of M1–M4
[26]. Finally, a relatively small C-terminal domain (CTD)
extends into the cytoplasm, interacting with cytosolic
proteins that regulate receptor anchoring and trafficking
[27–30]. The length of the CTD ranges between 30 and 50
amino acids depending on the subunit.
The AMPA-R subunits are subject to alternative splicing
and RNA editing [31]. The alternative splicing results in
flip and flop isoforms that are different by only nine amino
acids in the region encompassing S2 subfragment of the
LBD and the linker between the LBD and M4. Each splice
variant confers distinct channel properties to the AMPA-Rs
[32]. The relative abundance of the flip/flop variants in the
brain are developmentally regulated [33]. Nucleotide
sequences of the mRNAs of AMPA-R subunits are
enzymatically modified by the deaminase ADAR2 [34],
introducing amino acids that are not encoded by the
genome. This post-transcriptional modification, known as
RNA editing, occurs in two locations in the AMPA-R
subunits [35]. The first is the R/G site located within the
LBD immediately before the flip/flop splice site in GluA2–
4 subunits, and the other is the Q/R site only in GluA2
subunit located in the loop of the transmembrane segments
[36, 37]. The different molecular products produced by
RNA editing have distinct trafficking, maturation, and
gating properties [38]. Collectively, the alternative splicing
and RNA editing adds to the molecular complexity and
functional variety of AMPA-Rs in the brain.
Molecular Composition of Native AMPA-Rs
The core of the AMPA-R that forms the tetrameric ligand-
gated ion channel is made of the proteins encoded by the
GluA1–4 genes (Fig. 1c, d). The core of most native AMPA-
Rs are heterotetramers made of at least two of the four proper
AMPA-R subunits, GluA1–4[ 39]. However, when overex-
pressed, an individual AMPA-R subunit is capable of
assembling into a functional homotetrameric ligand-gated
ion channel [40]. A series of works identified that trafficking
of AMPA-Rs is governed by rules determined primarily by
the subunit composition of the tetrameric core of the
receptors, signifying the importance of the subunit
composition in AMPA-R function [41–43]. Attached to the
receptor core are the auxiliary subunits including stargazin/
TARPs (also known as g-2, g-3, g-4, g-5, g-7, and g-8) [44],
cornichon 2/3 [45], and CKAMP44 (also known as Shisa9)
[46]. Each auxiliary subunit has distinct function on receptor
trafficking and/or gating [47]. The molecular complexity of
the AMPA-Rs in brain is amplified by their co-assembly
with the various transmembrane auxiliary subunits. In
Caenorhabditis elegans, a transmembrane CUB domain
containing protein SOL-1 interacts directly with the gluta-
mate receptor subunit GLR-1 and is essential for glutamate
receptor function [48]. The mammalian homologues of SOL-
1 are NETO-1 and -2. The SOL-1 homologues in rodents
interact with kainate receptors [49] and NMDA receptors
(NMDA-Rs) [50]. The membrane topology of each auxiliary
subunit is shown in Fig. 1e.
Overview of Ultrastructural Studies of AMPA-Rs
In 1998, Eric Gouaux’s laboratory reported the first
structural data of the isolated LBD of AMPA-Rs [25]. The
crystal structures of the isolated LBD, also known as the
S1S2 construct, adopted a clamshell-like structure made of
two lobes (D1 and D2 lobes). The ligand glutamate binds to
the pocket of the clamshell and induces a conformational
change resulting in the closure of the clamshell [51].
Furthermore, two clamshells form dimers in the crystal
162 Mol Neurobiol (2010) 42:161–184packing and a series of studies on the structure–function
relationship of the receptor demonstrated that the dimeric
organization of the LBDs seen in the crystal structure is
physiologically relevant [51–57]. Because the mature
AMPA-Rs are tetramers while the LBDs are dimers, it
was proposed that the AMPA-Rs adopt a dimer-of-dimers
global subunit arrangement. Subsequently, using constructs
that have similar design principal as the original S1S2
construct, the X-ray structures of the isolated LBDs of
NMDA-Rs, kainate receptors, GluR0, and GluRdelta2
receptors were solved [58–64]. The design principle of the
S1S2 construct was also applied to the LBD of the mGluR1
[65], whose primary structure is actually more homologous
to the NTDs of the ionotropic glutamate receptors.
The first insights into the ultrastructure of the intact full-
length AMPA-Rs were provided by electron microscopy
Fig. 1 AMPA-R and auxiliary subunits. a Primary structure of a
subunit of AMPA-R. NTD N-terminal domain, LBD ligand binding
domain, TMD transmembrane domain, CTD C-terminal domain. The
LBD is made of S1 and S2 subfragments. The TMD contains alpha-
helices M1–M4. The linkers between the domains are also indicated. b
Domains of a subunit of AMPA-R. The large rectangle indicates the
membrane. The NTD, LBD, TMD, and CTD are coded in the same
color as in (a). c Tetrameric structure of the AMPA-R. In the tetramer,
ap a i ro fN T Dd i m e r( NTD2) is located most distal from the
membrane. A pair of LBD dimer (LBD2) forms the middle layer and
the tetrameric TMD is embedded in the lipid bilayer. The organization
of the four CTD (4xCTD) in the cytoplasm is currently not understood
but speculated to be flexible. Each modular unit is color coded as in
(a) and (b). d Negative stain single particle EM image of an AMPA-R
made of homotetrameric GluA2 [23]. The relation between the known
domains of the AMPA-R and the substructures of the EM image are
indicated. e Auxiliary subunits of AMPA-Rs. The schematics of the
membrane topology and domain organization of stargazin/TARP,
cornichons, CKAMP44, and SOL-1 are shown
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EM projection structures of the GluA2 tetramer
expressed and purified from Sf9 cells were reported
[68]. This study provided the overall dimensions of the
particles (approximately 11×14×17 nm) and the pseudo-
2-fold symmetry of the receptor. The 3D EM density map
of GluA2 tetramer expressed and purified from Sf9 cells
demonstrated overall 2-fold symmetry of the receptor but
consistency was not described with the known crystal
structures [69]. The possible discrepancy between the EM
structure and the crystal structures of the related domains
prompted the need to accumulate more data in the field to
understand the structure of the intact full-length AMPA-
Rs. In 2005, a method to purify homogeneous particles of
native AMPA-Rs from rat brain was developed and the
purified receptors were further analyzed using single particle
EM [66]. At the resolution of about 30 Å, the cryo-negative
stained single particle 3D EM structures of the native
AMPA-R containing auxiliary subunits stargazin/TARP and
the native AMPA-Rs without the stargazin/TARP were
reported [66, 67]( F i g .2). The EM structure of native
AMPA-Rs purified from rat brain [66, 67]l o o k e dv e r y
different from those of GluR2 homotetramers expressed and
purified from Sf9 insect cells [69, 70]. Of particular
importance, however, is that the sizes and shapes of the
individual globular densities observed in the EM density
map of the native AMPA-Rs were consistent with those of
the crystal structures of the GluA2 LBD and GluA2 NTD
[66, 71]. The structure also was consistent with the proposed
dimer-of-dimers assembly of the subunits. The electron
microscopy studies of native AMPA-Rs also revealed the
global conformational changes of the receptor upon desen-
sitization [66, 67]( F i g .3). The detail of this study is
discussed in the later section.
Fig. 2 Low-resolution 3D view of the native AMPA-R obtained by
single particle EM. a Cryo-negative stain 3D EM density map of
native AMPA-R containing stargazin/TARP at the resolution of
around 30 Å. Three different views of the particles are shown. The
domains that correspond to each globular substructure are shown.
NTD2 NTD dimer, LBD2 LBD dimer, and TMD4 TMD tetramer. b The
placement of the crystal structures into the EM density map in (a). The
crystal structures used are: extracellular domain of mGluR1
(PDB:1EWV, dark blue and dark green); ligand binding domain of
GluR2 (PDB:1LBC, light blue and light green), and transmembrane
segment of KcsA (PDB:1BL8, red). c Cryo-negative stain 3D EM
density map of native AMPA-R without stargazin/TARP at the
resolution of around 30 Å. Three different views of the particles are
shown. The domains that correspond to each globular substructure are
indicated as in (a). The size of the TMD is significantly smaller than
the structure shown in (a). The difference in the size of TMD accounts
for the auxiliary subunits stargazin/TARP. The images were repro-
duced from [66, 67]
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NTDs of the GluA2, GluK2, and GluN2B were solved [71–
74]. The expression of the NTDs required demanding systems
that used eukaryotic hosts such as the HEK cells and the Sf9
cells. The NTD crystal structures of GluA2 and GluK2 were
homodimeric, while the GluN2B NTD was monomeric.
Interestingly, Aricescu’s laboratory isolated tetrameric GluA2
NTD in solution and its crystal structure revealed a dimer-of-
dimers arrangement of the NTDs [71]. Similar tetrameric
arrangement of the GluA2 NTD was also observed in the
crystal packing of GluA2 NTD from Gouaux’s laboratory
[72]. Furthermore, the global domain arrangement of the
GluA2 NTD tetramer in these crystals was consistent with the
NTDs in the cryo-negative stain EM density map of the native
AMPA-R without the stargazin/TARPs [71].
An important breakthrough was the study on the crystal
structure of the near-intact AMPA-R, the product of GluA2-
cryst construct, reported in December 2009 from Eric
Gouaux’sl a b o r a t o r y[ 75]. The X-ray crystallography power-
fully resolved the atomic structures of the individual domains
and the tetrameric assembly of the almost intact subunits of
the antagonist bound AMPA-Rs. The structure at the high
resolution proposed many important chemical mechanisms
involved in the process of ligand binding, gating, desensiti-
zation, and modulation (discussed in the later sections). The
arrangement of the NTDs in the GluA2cryst tetramer was
consistent with the crystal structure of the tetramers formed
of the isolated GluA2 NTD [71]. The overall domain
arrangement of the X-ray structure was different but showed
resemblance to the previous EM structures. With careful
inspection and comparison, the two structures can be
interpreted in a consistent logical framework, as described
in detail in the later section (Fig. 4).
By controlling the timing of GluA2 expression using a
DOX inducible expression system, a recent study showed
that subunit dimers are the intermediate biosynthetic form
of AMPA-Rs [23]. Comparison of the single particle EM
structures of the dimeric and the tetrameric AMPA-R
revealed the possible gross conformational changes that
occur during AMPA-R maturation. Furthermore, the sepa-
ration of the LBDs is required for maturation. The study
also proposed a model for the connection between the
individual domain in the tetrameric AMPA-R. The detail of
this study is discussed in the later section (Figs. 6 and 7).
One of the main reasons that the structural studies of intact
glutamate receptors lagged behind compared to the acetyl-
choline receptors [76–79] is the lack of good biological
specimens. Specifically, unlike the electric organs of the
electric rays that are rich in homogeneous population of Ach
receptors, there was no known biological specimen that has a
high concentration of homogeneous glutamate receptors. The
brain was obviously rich in glutamate receptors, but the
receptors were not homogeneous enough to use without
purification. The important biochemical breakthroughs were
(1) the successful engineering, expression, and purification
of the recombinant ligand binding domain (the S1S2
construct) [25], NTD [71, 72, 74], and the near full-length
receptor (the GluA2cryst construct) [75] and (2) the
development of the method to purify intact AMPA-Rs from
the rat brain [66, 67]. The former approach was used to
crystallize the receptors for structural determination by X-ray
crystallography, while the latter was used for structural
d e t e r m i n a t i o nb ys i n g l ep a r t i c l ee l e c t r o nm i c r o s c o p y .
Biochemistry of Endogenous AMPA Receptors
Detergent Extraction and Purification of Endogenous
AMPA Receptors
The AMPA-Rs are known to be highly soluble when
extracted from the brain membrane using mild detergents.
“Mild detergents” means either zwitter ionic or non-ionic
detergents with a large hydrophobic group. The choice of
Fig. 3 Different conformations of native AMPA-R. The AMPA-R
particles adopt different conformations in the presence of various
drugs. Unliganded, NBQX (30 µM) treated, and glutamate (1 mM)+
CTZ (330 µM) treated particles, respectively, adopt conformation
shown in left. In this conformation, the two NTD dimers are close to
each other. The structural difference between the three conditions was
not detectable at the resolution of the study. Right box—particles that
are treated with glutamate (1 mM) adopt conformations in which the
two NTD dimers are separated. Each NTD dimer is indicated by the
short arrows. The images were reproduced from [66]
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assembly of the AMPA-Rs. The detergent solubility of
the brain AMPA-Rs was investigated by Blackstone and
Huganir [80]. In their study, they solubilized the brain
membrane using different detergents (Triton X-100, octyl-
β-D-glucopyranoside, digitonin, and CHAPS) and deter-
mined that a high yield of H
3-AMPA binding activity was
recovered from brain membrane extracted by 0.5%
CHAPS.
Not every detergent can maintain the intact macromo-
lecular assembly of the AMPA-R complexes. In fact, the
spectrum of effective detergents is very limited. More
specifically, solubilizing brain membrane with decylmal-
toside (0.6%), dodecylmaltoside (0.1%), or octyl-β-D-
glucopyranoside (0.3%) all resulted in recovery of par-
ticles with smaller molecular weights [67]. Investigation
of these smaller particles by negative stain EM confirmed
that these smaller particles adopt shapes that are distinct
from the views of the tetrameric AMPA-R model.
Interestingly, as described below in the section of
recombinant GluA2 tetramers, the best choice of detergent
varies between recombinant and native receptors. This
may suggest that the stability in detergent is different
between recombinant homotetramers and native heterote-
tramers. Alternatively, the composition of the surrounding
lipids and the auxiliary subunits in each experimental
system are different and confer distinct stability in
different detergents.
Fig. 4 Atomic view of the AMPA-R from the crystal structure of
GluA2cryst. The crystal structure of GluR2cryst (PDB:3KG2) [75]
viewed from two different angles. In each row, the tetramer is shown
on the left. Four subunits are denoted as A–D, and each subunit is
coded in different colors. The structures on the right side show only
two subunits out of the four. Within each row, the sum of the two
structures on the right corresponds to the tetrameric structure shown
on the left. The structures in the second row are viewed after rotating
each structure on the top by 45° around the global axis perpendicular
to the membrane. The locations of NTD, LBD, and TMD layers are
indicated on the left end of each row. The M3 alpha-helices are
indicated by the arrows. The subunits A and C have longer M3 helices
and the LBDs of these two subunits form the inter-dimer contacts
between the two dimeric NTDs (indicated as a black rectangle in the
top middle structure). The subunits B and D have shorter M3 helices
and the NTDs of these two subunits form the inter dimer contacts
between the two dimeric NTDs (indicated as a black rectangle in the
top right structure). The A–B and D–C are the pairs of subunits that
form the NTD dimers, whereas A–D and B–C are the pairs that form
the LBD dimers. The TMD has 4-fold symmetry made by all four
subunits. The images were prepared using pyMOL
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portant roles in purifying AMPA-Rs from the brain [66,
67]. The anti-GluR2 (GluA2) C-terminal antibody has a
very convenient characteristic of being able to efficiently
release the bound antigen by competitive elution of the
epitope peptide. Furthermore, the antibody affinity was
high enough to enrich GluA2 subunit containing AMPA-Rs
from the brain lysate and the peptide elution could detach
all the receptors that were bound to the column. These
advantages and the availability of reagents made AMPA-Rs
a good target for purification among other glutamate
receptors. Importantly, antibodies against other glutamate
receptor subunits do not necessarily have such character-
istics (unpublished observations).
The Proteins that Co-Purify with the Native AMPA-Rs
The AMPA-Rs in the brain interact with a variety of
proteins, and thus when one purifies AMPA-Rs from brain
tissue many proteins co-purify with the receptors. Precisely
identifying the proteome of the AMPA-R is itself an
important area of research that may lead to identifying the
novel molecular mechanism of AMPA-R function and
modulation.
Most of the initial studies that identified protein
interactors of AMPA-Rs used yeast two-hybrid screening.
In this approach, cytoplasmic fragments of the AMPA-R
subunits were used as a bait to screen a brain cDNA library
to search for cDNAs that encode interacting partners. This
approach identified many C-terminal interactors, such as
GRIP [81], PICK1 [82], NSF [83–85], AP-2 [86], protein
4.1 [87], RIL [88], and IQGAP [89]. Based on drawing an
analogy to the interaction between GluN2 and PSD-95, the
interaction between GluA1 and SAP97 was identified by
directly testing the interaction [90]. The C-terminus of
AMPA-R subunits is also a substrate for kinases that
regulate receptor function [91, 92]. A subset of these
proteins was identified by LC/MS/MS when GluA2
containing AMPA-Rs were purified from brain [45, 46,
66, 93]. The experimental conditions used to biochemically
isolate the receptors were suboptimal to extract some of the
membrane complexes. Furthermore, the PDZ domains and
their ligands interact at dissociation constants [94] that will
not allow tight association, and thus may not be stable
enough to co-purify large quantities.
A series of data demonstrated the functional significance
of stargazin and its homologues, the TARPs in AMPA-R
trafficking and channel modulation [44, 95]. Purification of
native AMPA-Rs from brain subsequently confirmed the
presence of stargazin/TARP [66, 96]. Further experiments
have identified novel binding partners in the membrane
during the past few years. Chemical crosslinking followed
by immunoprecipitation identified N-cadherin as interactor
[93]. More intensive purifications and analyses have
identified cornichons [45] and CKAMP44 (also known as
shisa 9) [46]. Importantly, the latter two proteins co-purify
with native AMPA-Rs without using chemical crosslinkers
in stark contrast to the interaction between the GluA2 NTD
and N-cadherin. The cornichons and CKAMP44 are
transmembrane proteins that belong to completely different
families. From a different line of research, conotoxin con-
itok-itok was identified that is homologous to CKAMP44/
shisha9 [97]. It will be interesting to see if shisa 7, a
homologue of shisa 9 in the rat genome, also has similar
function to CKAMP44/shisa9.
Biochemical manipulations are available that can remove
auxiliary subunits from the AMPA-Rs. For example,
purifying the AMPA-Rs with CHAPS and exchanging the
detergent into DDM using gel filtration was reported as a
manipulation that can remove the stargazin/TARPs from the
tetrameric channel core [66, 67]. Functional interaction
between stargazin/TARPs and AMPA-Rs can decrease in
the presence of a high concentration of glutamate [98].
Consistently, for receptors that were solubilized in Triton
X-100, application of high concentration of glutamate to
the receptors also dissociate stargazin/TARPs from AMPA-
Rs [99]. However, glutamate induced dissociation of
stargazin/TARPs was not observed for those receptors
solubilized in CHAPS [66]. The detailed biochemical
properties of the interactions between AMPA-Rs and the
auxiliary subunits (cornichons and CKAMP44) that were
identified recently are still unknown.
The majority of the endogenous cytosolic interactors of
AMPA-Rs can be removed by washing the membrane with
caotropic salts [66]. This manipulation enriches for the
integral membrane proteins. Highly pure native AMPA-Rs
were obtained from P2 brain membranes that were washed
with KI and urea. Treating synaptosome enriched P2
membrane with 1 M KI and 4 M urea does not affect the
conformation of the AMPA-Rs purified from rat brain. We
have compared the structures of the AMPA-Rs that were
purified from P2 membranes that were washed with 1 M KI
followed by 4 M urea and those that were not washed
(unpublished observation). The EM structures of the
AMPA-Rs obtained from both preparations were indistin-
guishable. A recent publication claims that urea destabilizes
the native conformation of AMPA-Rs [70]. However, in
[70], the authors omit the 1 M KI wash and omit adding
30 µM of AMPA-R specific full-antagonist NBQX during
purification. To our knowledge, the inclusion of the NBQX
is critical to obtain a structurally homogeneous preparation
of AMPA-Rs. Therefore, the reported urea-induced desta-
bilization of the AMPA-R is a phenomenon observed in a
very specific experimental system. It is important to note
that 4 M urea wash of the membrane is an effective
approach in improving the purity and quality of other
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aquaporins [100–102]. In addition, vesicles that were
washed with KI maintain their ability to bind to molecular
motors and thus can be used for in vitro motility assays,
suggesting that motor acceptors on the vesicles are
unaffected by the KI wash [103].
Controlling the stability of proteins complexes formed
between AMPA-Rs and the individual auxiliary subunit will
be important in determining the structural basis and
regulation of their function. With an accurate understanding
of the mechanism of endogenous modulators, new methods
of manipulation can be discovered. This may ultimately
lead to developing therapeutic means for various disorders
affected by the dysfunction of AMPA-Rs.
Single Particle EM Studies of Brain-Derived AMPA-Rs
AMPA-Rs purified from the rat brain were studied using
cryo-negative staining and single particle electron micros-
copy [66, 67]. Native AMPA-Rs purified from brain were
cryo-protected using glycerol, attached to the surface of a
thin carbon membrane, negative stained using 0.7% uranyl
formate, and quickly plunged into liquid nitrogen to
achieve vitrification of the specimen [104]. Cryo-
protection and quick freezing enable ultrastructural preser-
vation of the negative stained specimen. The frozen grid
was observed under liquid nitrogen temperature in the
transmission electron microscope using low dose procedure
(below 20 electron/Å
2) to minimize radiation damage
caused by the electron beam. The advantage of cryo-
negative stain over the conventional negative stain is the
capability to image hydrated macromolecules maintaining
native structure. Cryo-negative staining was also used in the
study of potassium channel [105].
The global domain arrangement of the native AMPA-R
is shown in Fig. 2. The EM density map was interpreted in
two steps; first by identifying the NTD and the TMD using
Fab labeling, and then by placing the known crystal
structures of the individual domains. The two dimers of
the NTDs are located at the top of the particles and have the
appearance of two elongated densities. The Fab fragment
that recognizes the NTD binds to these densities, and thus
each of these densities was interpreted as one NTD dimer.
Because the Fab that recognizes the C-terminus of the
receptor consistently labeled the bottom part of the
particles, the bottom density was interpreted as the TMD.
The sizes and shapes of the EM densities corresponding
to the two NTD dimers were consistent with the crystal
structure of the dimeric mGluR1 LBD [65] (Fig. 2b).
(When the EM structure was published, the crystal
structures of the GluA2 NTD were not available. The
mGluR1 LBD is a close homologue of GluA2 NTD whose
crystal structure was available at the time.) Later it was
shown that the crystal structure of the GluA2 NTD
tetramers could also be placed into these densities [71].
The existence of two dimeric NTDs in the structure was
consistent with the proposed dimer-of-dimers organization.
The densities immediately below the two NTD dimers were
consistent with size and shapes of the two dimeric crystal
structures of the isolated LBD dimers [51]. The density of
the TMD, however, was larger than what would be
expected if the structure was made only by the four GluA
subunits. The LC/MS/MS identified that stargazin/TARPs
co-purified with the native AMPA-Rs. Immunolabeling of
the particles with Fab fragments that specifically recognize
the C-terminus of the stargazin/TARPs consistently labeled
the bottom part of the transmembrane density, indicating
that the large transmembrane density contained the starga-
zin/TARPs. Consistently, when the particles were washed
with decylmaltoside or dodecylmaltoside, the auxiliary
stargazin/TARPs were removed as judged by Western
blotting, and the size of the transmembrane density
decreased (compare the TMD of Fig. 2a, c). This indicates
that the interaction between stargazin/TARPs and AMPA-
Rs is sensitive to detergents. The interpretation of the EM
density map provided a conceptual link between various
structural and molecular data in the field.
Another important finding was the glutamate-induced
conformational change of the NTD dimers, more specifi-
cally a lateral displacement of the two NTD dimers (Fig. 3).
The conformational change was blocked by the antagonist
NBQX or the inhibitor of desensitization CTZ, indicating
that the lateral displacement of the NTD dimers is related to
desensitization. This concept was particularly novel at the
time because the lateral movement of the NTD dimers was
unpredictable from the glutamate-induced clamshell closure
observed in the crystal structures of the isolated LBD
dimers. Recently, the crystal structure of GluA2cryst
together with the crystal structure of the isolated LBD of
the S729C mutant that adopts the “desensitized-like”
conformation [52] predicted a mandatory displacement of
the NTD dimers during desensitization [75], confirming
and extending the desensitization-related lateral displace-
ment of the NTD dimers proposed from the earlier EM
studies.
Due to the limited resolution of the EM density map,
many questions remained unanswered. For example, how
individual domains are connected within the tetrameric
assembly was not resolved. Other than the gross
conformational change related to desensitization, the
detailed conformational changes and mechanisms of
gating were not clear. It was also unclear whether the
conformational changes of AMPA-Rs solubilized in
detergent faithfully represent the conformational changes
of the receptors in the membrane. As discussed above,
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predicts similar conformational changes [75]. The mag-
nitude of the lateral displacement of the NTD dimers was
g r e a t e ri nt h eE Ms t u d yt h a nw a sp r e d i c t e df r o mt h eX - r a y
study. Although it may not completely explain the cause of
the difference, one likely source is the different length of
the linker connecting the NTD and the LBD. In the
GluA2cryst, NTD–LBD linker is significantly shorter than
the wild-type sequence. The EM structure was obtained
from images of particles attached to the carbon membrane
in the presence of negative stain (0.7% uranyl formate),
and thus may have caused small distortions to the global
structure. However, in many cases the negative stain EM
structure provides a good approximation of the actual
macromolecular structure [104, 106].
Recombinant Expression of Homotetrameric AMPA
Receptors
Because AMPA-Rs from brain are molecularly heteroge-
neous, they are not suited for detailed structural studies.
Expression and purification of membrane proteins in
general are challenging. Complications arise for many
reasons that are still incompletely understood. A recombi-
nant membrane protein must express well, fold correctly,
and not be toxic to the host cell to be useful for biochemical
studies. Modest expression facilitates correct folding of the
protein [107–109]. Recombinant AMPA-Rs have advan-
tages over native receptors. Specifically, subunit composi-
tion can be controlled and genetically modified receptors
can be generated to study structure–function relationships.
All of the expression systems reported so far use eukaryotic
expression systems in order to express AMPA-Rs. More-
over, most of the studies are done using the homotetramers
of the GluA2 subunit.
Homotetrameric GluA2 Expressed and Purified from HEK
Cells
Studies have reported stable mammalian cell lines that
express functional AMPA-R subunits [110, 111]. These
stable cell lines were developed to study channel function
using electrophysiology or to conduct drug screening, and
thus purification tags are not included in the receptor
subunits. To purify AMPA-Rs from recombinant sources,
the expression must be high enough so that the cell culture
can be done at a reasonable scale. However, when
expressed at high levels, many of the glutamate receptor
subunits are toxic to the cells because there is glutamate in
the media (more specifically in the FBS) that can activate
the receptors. Furthermore, too high expression of AMPA-
R subunit causes protein aggregation. For instance, tran-
sient expression using plasmid transfection gave good yield
but the majority of the AMPA-Rs aggregated and elute in the
void fraction in the gel filtration chromatography [23].
HEK cells are a useful host cell line for membrane
protein expression [112, 113]. The GluA2 homotetramers
assemble without aggregation or misfolding when
expressed at a modest level using stable HEK cell lines.
Based on the yield of purification, it was estimated that at
least 15,000~20,000 GluA2 tetramers are expressed per
cell. No auxiliary stargazin/TARP subunits were detected in
the purified recombinant GluA2 fraction when examined by
Western blotting using a pan-TARP antibody and by protein
identification using liquid chromatography followed by
tandem mass spectroscopy (LC/MS/MS) [23]. This sug-
gests negligible contribution of HEK cell-derived stargazin/
TARPs during AMPA-R assembly in this system. It is
possible, however, that endogenous g-7 [114] that is not
immunoreactive with pan-TARP antibody may be present
in HEK cells. It is not clear if any endogenous cornichon
homologues and CKAMP44/Shisa9 homologues are
expressed in HEK cells.
Shanks et al. [23] systematically compared the structures
of GluA2 tetramer that were expressed constitutively in HEK
cells and GnTI(−) HEK cells. Recombinant GluA2-FLAG
was purified from cellular membrane that was solubilized
using 0.25% dodecylmaltoside in the presence of 30 µM
NBQX. Immunoaffinity purification using anti-FLAG M2
column was followed by gel filtration using a Superdex200
column. Interestingly, CHAPS, which was selected as a good
detergent to extract AMPA-Rs from brain, did not preserve
the ultrastructure of the tetrameric GluA2 from HEK cells
(unpublished observation). They conclude that the projection
structures of each of these receptors are indistinguishable
from the native AMPA-Rs void of stargazin/TARPs purified
from brain at the resolution of around 20 Å.
Homotetramers of GluA2cryst Expressed and Purified
from Sf9 Cells
The Sf9 insect cells were used as host to express
recombinant AMPA-R subunits [75, 115–117]. Among
these, the GluA2flip splice variant was developed in Eric
Gouaux’s laboratory to maximize the expression and stability
of the protein for X-ray crystallographic studies of AMPA-R
structure. The resulting GluA2cryst construct contains
various small modifications throughout the receptor, is
capable of gating in the presence of CTZ, and expresses in
Sf9 insect cells at a quantity high enough to conduct
crystallography. It has been shown that the AMPA-Rs
expressed in Sf9 cells are functional [115, 116]. The wild-
type GluA2 homotetramers conduct very small current [40],
but the GluA2cryst conducts even smaller current compared
to the wild-type GluA2 (supplementary figure of [75]).
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levels of glutamate-induced currents in the presence of
CTZ (supplementary figure of [75]).
The challenge of obtaining high-quality AMPA-Rs for
structural studies can be understood when we look at the
details of the construct engineering reported in [75]. First,
gel filtration was used to identify GluA2flip as the subunit
that expresses and folds the best in Sf9 cells. GluA2flip was
further engineered as follows: approximately 35 amino
acids of the cytoplasmic C-terminal domain were deleted.
Six out of 17 amino acids were deleted from the linker that
connects the NTD and the LBD. Two N-linked glycosyl-
ation sites within the linker were mutated such that sugar
cannot be added. Nine amino acids in the NTD and the
LBD were mutated. Two residues in the transmembrane
segments were also mutated. The residue in the Q/R RNA
editing site was Q, the non-edited form. A His tag was
placed after the M4 to facilitate purification. The GluR2-
cryst was extracted from Sf9 cells using 40 mM dodecyl-
maltoside. The purification using cobalt-charged chelating
sepharose was followed by gel filtration. During the gel
filtration, the detergent was exchanged to 1 mM undecyl-
maltoside and 0.01 mg/ml phospholipids (a mixture of
POPC/POPE/POPG—3:1:1) was included.
The Crystal Structure of the Near-Intact AMPA-R
made of GluR2cryst Homotetramer
The GluR2cryst homotetramer in complex with the
competitive antagonist ZK200775 was crystallized and
its structure was determined at 3.6-Å resolution [75]. The
structure represents the closed state of the channel. The
global architecture can be subdivided into three layers: the
NTD layer, LBD layer, and the transmembrane (or channel
pore) layer (Fig. 4) .T h eN T Dl a y e ra n dt h eL B Dl a y e ra r e
each formed by a pair of NTD dimers and a pair of LBD
dimers, respectively. The protomers within the NTD and
LBD dimers are related to each other by the 2-fold axis
perpendicular to the membrane plane. Using the same
symmetry axis, the TMD has approximately 4-fold
rotational symmetry, whereas the architecture of the top
part of the channel pore with the linker sequence that
connects to the LBD has a 2-fold rotational symmetry. The
relative arrangement of the two NTD dimers in the
GluA2cryst was very similar to what was observed in the
crystal structure of the tetrameric GluA2-NTD [71, 72].
The interface between the two NTD dimers was made by
the inner two subunits that are closer to the global 2-fold
axis. The structures of each NTD dimer were indistin-
guishable from what was observed in the dimeric crystal
structures of the NTD. The C-termini of the NTDs connect
to the N-termini of the LBDs through the linker sequence.
In this connection, the pair of subunits that form single
NTD dimer is not the pair of subunits that form the LBD
dimers. The structures of the LBD dimers were very
similar to the previously reported structure except that the
antagonist ZK200775 locked the pocket of the clamshell-
like structure of the LBD into a further extended
conformation than the other competitive antagonists. A
novel small interface between the two LBD dimers was
identified and was predicted to form a weak dimer–dimer
interaction.
The domain arrangement in wild-type GluA2 was
proposed by extending the models from the GluA2cryst
structure. Cysteine residues were introduced into the wild-
type GluA2 sequence at locations that were predicted to
make close inter-domain contacts, specifically the inter-
NTD dimer contact point (V209C), inter-LBD dimer
contact point (K663C and I664C), and the inter-TMD
contact point (M629C). When expressed in HEK cells, the
mutant subunits formed disulfide bonds, indicating that the
residues mutated to cysteines were within close proximity.
The architecture of the transmembrane domain of the
GluR2cryst contained many of the concepts gained from
the previous studies that proposed the topology of the
transmembrane segments [26, 118]. Specifically, the M1, 3,
and 4 form alpha-helices and span the membrane and the
M2 is part of a reentrant loop. The structure around M2 that
corresponds to the ion selectivity filter in the potassium
channel [119] was largely disordered in the crystal structure
of GluA2cryst and its structure remained unclear. The
channel pore was lined by the M3 helices. The alpha-
helices of M3 cross near the outer side of the membrane
and form a narrow constraint creating an occlusion of the
putative ion permeation pathway. The region around the
crossing of the M3 helices is made of the highly conserved
amino acid sequence among the glutamate receptors
(SYTANLAAF) that is mutated in the lurcher mutant mice
[120]. The pore diameter of the ion permeation pathway
was the narrowest where the conserved amino acids
SYTANLAAF were located in the GluA2cryst structure.
M4 is not part of the central ion permeable pore but an
extensive interaction between the M4 helix and the others
were detected.
The core gating machinery that has 2-fold symmetry is
made of the region between the LBD and M3. The
connection between the LBD and the M3 contributes
largely to the transition of symmetry between the LBD
layer (2-fold rotational symmetry) and the transmembrane
layer (4-fold rotational symmetry). The lengths of the M3
alpha-helices are not equal in all four subunits. According
to their length, the four M3s can be subdivided into two
pairs. The pairs are defined such that within each pair the
two M3s have a 2-fold rotational symmetry around the
global rotational axis perpendicular to the membrane plane.
170 Mol Neurobiol (2010) 42:161–184In other words, if one draws a square by connecting the
four M3s that appear in a cross section tangent to the
membrane plane, the two M3s that are located diagonally
form one pair. The length of the M3 in one of the pairs
is longer than the other. The shorter M3s are connected
to the two LBDs that do not form the inter-LBD dimer
interface. Because the ends of these two LBDs that
connect to the shorter M3s are located farther away from
the channel pore, these M3–LBD linkers are more
extended compared to the other two M3–LBD linkers that
connecttheLBDswiththelongerM3s.Consequently,thetwo
LBDs that form the interface between the two LBD dimers
(Fig. 4, top middle structure, rectangle) are derived from the
two subunits that adopt the longer M3 helices and the M3–
LBD connection in these subunits are shorter. In relation to
the NTDs, the subunits that adopt the shorter M3 are the
same subunits as those that contribute to forming the
interface between the two NTD dimers (Fig. 4, top right
structure, rectangle). When the polypeptides of an individual
subunit are traced carefully, it is immediately recognized that
each subunit contributes to the overall tetrameric structure in
either one of the two modes (in Fig. 4, subunits A and C are
one mode, whereas B and D are another).
Insights into the mechanism of gating were gained from
the architecture of the channel core and the geometrical
arrangements of the linkers connecting the membrane
spanning segment and the LBD. The displacement of the
M3 helices that form the narrow constriction of the ion
permeable path will be necessary for gating. The crystal
structure of the GluA2cryst predicts that the shorter M3
alpha-helices will undergo larger displacement upon the
glutamate-induced closure of the clamshell-like LBDs.
Conversely, the longer M3 alpha-helices will have a smaller
degree of displacement and thus may contribute less to the
gating. In this model, the pair of LBDs that are connected
to the longer and shorter M3s, respectively, contributes
differently to the gating. Based on the global domain
arrangements of the LBD and the cysteine crosslinking
experiments, it was suggested that in the NMDA-Rs the
two GluN1-derived LBDs form the interface between the
two LBD dimers and thus connect to the longer M3 alpha-
helices. GluN1 is the glycine binding subunit of NMDA-
Rs. Because the GluA2cryst structure predicts that the
LBDs connecting to the longer M3 contribute less to
gating, a similar principal may explain why glycine
contributes less to channel gating in the absence of
glutamate.
Insights into the mechanism of desensitization were
gained by comparing the crystal structure of GluAcryst and
mutant LBD carrying the S729C mutation, a mutant that
locks the LBD in a conformation that mimics the
desensitized state [52]. The LBD clamshell is made of
two lobes denoted as D1 and D2 lobes [25]. The D2 lobe is
the lower lobe of the LBD clamshell that is closer to the
membrane. The D2 lobes of the GluA2cryst in complex
with the competitive antagonist ZK200775 superimpose
well with the D2 lobes of LBD S729C mutant in
complex with glutamate. The clamshell of the LBD
S729C is closed by glutamate but the D2 lobes are
separated in the same way as the LBDs in the
GluA2cryst whose clamshell is open and ion channel is
closed. This observation and the results from previous
studies [52, 57] collectively suggest that desensitization
results from the rupture of the LBD dimer that is made by
the D1 lobes. Importantly, the GluA2cryst structure
predicts that when the rupture of the D1 lobes happens
during desensitization, the NTD together with the NTD–
LBD linker must move. More precisely, during desensiti-
zation, it was predicted that the distances between and
within the NTD dimers must change. This prediction is
also supported by the previous single particle EM study
that experimentally demonstrated the distinct conforma-
tion of the NTD dimers in the presence or absence of
glutamate and CTZ [66], and the electrophysiological
study that demonstrates the importance during gating of
multimerization state of the NTDs [121]. It is well known
that the binding of Zn
2+ and ifenprodil to the NTDs can
modulate channel function of the NMDA-Rs [122–126].
By inverting the cause and consequence, the predicted
mandatory movement of the NTDs upon desensitization is
also consistent with the channel-modulating function of
the NTDs in NMDA-Rs.
The crystal structure of GluA2cryst raises many new
questions. The current structure of GluA2cryst represents a
channel-blocked structure. Different conductive states have
been reported for AMPA-Rs, suggesting the existence of
more than one conformation when the channel is open
[127]. Understanding the architecture of the different gating
states will be the next challenge. As described in the earlier
sections, gating of AMPA-Rs is modulated by auxiliary
subunits. Which part of the AMPA-Rs is involved in the
functional modulation by the auxiliary subunits such as
stargazin/TARPs? The cytoplasmic C-terminus of the
stargazin/TARPs is critical for modulating AMPA-R gating
[99, 128], and thus any potions of the AMPA-R that are
exposed to the cytoplasm are candidate interacting targets
of stargazin/TARPs. In the GluA2cryst structure, however,
the cytoplasmic C-terminal and part of the M2 reentrant
loop are unresolved. Functional interactions exist between
stargazin/TARPs and the residues in the narrow constriction
of the AMPA-Rs [129]. The Q/R editing site located near
the M2 is critical for the polyamine block of the AMPA-Rs
[130]. The polyamine block of AMPA-Rs is also modulated
by stargazin/TARPs [131]. Collectively, the opening of the
pore on the cytoplasmic side is the likely candidate for the
cytoplasmic interaction between stargazin and AMPA-Rs.
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in channel modulation [132]. The structural and biochem-
ical data that support the complex mechanisms of modula-
tion remain to be seen.
The structure of the GluA2cryst provided mechanistic
interpretation to various experimental observations made on
the structure–function relationship of the glutamate recep-
tors. Many principles that govern the assembly and
architecture of the GluR2cryst are likely extendable to
other glutamate receptors. However, the structure and
mechanism of the NTDs of the NMDA-Rs are suggested
to be different from AMPA-Rs [133]. The NMDA-Rs are
obligate heterotetramers that require the essential subunit
GluN1. The crystal structure of the heterodimer formed of
the LBDs of GluN1 and GluN2A together with the
cysteine crosslinking study (E699C) of the GluN1 subunit
suggests that, at the LBD level, the NMDA-Rs are
assembled as a dimer of heterodimeric LBDs [59]. In
contrast, currently there is no structural evidence that
supports that the arrangement of the NTDs in the NMDA-
Rs follows the same principle as the AMPA-Rs. However,
electrophysiologicalrecordingsfromGluN2subunitscarrying
mutation in the NTD suggest a model in which NTDs of
GluN1 and GluN2 heterodimerize [134]. The affinity of the
NTD dimer in kainate receptors is much lower than that of
the AMPA-Rs [74]. If the affinity between the NTD dimer is
lower in non-AMPA-type glutamate receptors, it is possible
that depending on the conformational state and the phase of
the assembly process the domain arrangement of the NTDs
will dynamically change. In this view, the proposed domain
arrangements in the NMDA-Rs may represent one state of
the receptor and the mechanism around the NTDs will
require further experimental characterization.
Comparison of the Global Domain Arrangements
of Brain AMPA-Rs and GluA2cryst Homotetramers
Thestructuraldataofamoleculeobtainedusingsingleparticle
EM and X-ray crystallography provide important overlapping
and non-overlapping information [135]. A quantitative
comparison between the EM density map and X-ray crystal
structure can potentially identify sub-structures that are more
flexible in solution, providing dynamic information about the
molecule. As discussed above, the crystal structure of the
GluA2cryst at the resolution of 3.6 Å contains a considerable
amount of detailed ultrastructural information about the
AMPA-R [75]. Since the resolution of the EM structure of
the native brain AMPA-Rs is at around 30 Å [66, 67], the
crystal structure and the EM structure can only be compared
at the level of the global domain arrangements. Interestingly,
the global domain arrangements of the two structures are
different. However, they are very much related.
The size and shape of the globular features seen in the
EM density map were consistent with the known crystal
structures of the related domains that were in the PDB. The
crystal structure of the GluA2 NTD tetramer can be placed
into the densities corresponding to the NTDs of the EM
structure of native AMPA-R void of stargazin/TARPs [71].
The consistency between the crystal structure of the
tetrameric GluA2 NTD and the low-resolution EM density
map suggested that the inter-domain contacts seen in the
crystal may be preserved in the full-length tetrameric
receptor. The arrangements of the two NTD dimers in the
crystal structure of the tetrameric GluA2 NTD [71] and the
crystal structure of the tetrameric GluA2cryst [75] are
indistinguishable, and thus the global arrangements of the
NTDs in the GluA2cryst tetramer are in agreement with the
low-resolution EM map (Fig. 5b). However, when com-
pared side by side, it is immediately recognized that the EM
structure is shorter than the GluR2cryst structure (Fig. 5a).
The densities that correspond to the NTD dimer in the EM
structure are tilted in one direction, whereas in the X-ray
structure they are standing upright (Fig. 5a; the pivot axis of
the tilt is indicated by the red arrows). The difference in the
arrangements of the NTDs in the two structures contributes
to the different heights and the difference in the overall
symmetry (Fig. 5c). This tilt is the major cause of
asymmetry that was observed in the EM structure. The
linker that connects the LBD and the NTD in GluR2cryst is
engineered such that it is six amino acids shorter and two
predicted glycosylation sites [26, 136] are removed.
Sobolevsky et al. [75] reported that these modifications
were necessary to obtain crystals. Proteins with flexible
conformation are more difficult to crystallize, and thus it
makes sense if the linker that connects the LBD and NTD is
flexible in the native AMPA-Rs that have a longer
glycosylated linker. But simplifying the linker would
reduce the structural complexity and conformational variety
intrinsic to the NTD–LBD connection. Consistently, the
NTD dimers were arranged in a variety of angles relative to
the LBDs in the projection structures of the negative stained
EM images of the native AMPA-Rs from brain [66, 67].
The NTDs of the AMPA-R bind to the cell adhesion
molecule N-cadherin [93] and also to Narp and NP1 that
have synapse-inducing function [137, 138]. These inter-
actions are part of larger trans-synaptic protein networks in
the synaptic cleft. The pre- and post-synaptic membranes
are dynamic and accordingly the synaptic cleft is subject to
structural plasticity [139, 140]. Furthermore, recent studies
have shown that rapid lateral movements of the AMPA-Rs
along the plasma membrane are critical for synaptic
plasticity [141]. The flexibility between the NTD and the
LBD may play an important role in accommodating the
dynamic capacity of the protein networks in the synaptic
cleft.
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resolution density map provided the first ultrastructural
information related to the global domain arrangement of the
native AMPA-Rs. The extensive detail of the inter-domain
contacts in the AMPA-Rs was revealed by the crystal
structure of the tetrameric GluAcryst. However, because the
linker between the LBD and the NTD was significantly
engineered, there is a possibility that some functionally
relevant structural information around the NTDs may not
be contained in the GluR2cryst crystal structure. The
current atomic structure of the GluR2cryst bound to
competitive antagonist represents a blocked channel state.
The single particle EM analysis revealed a difference in
global conformation between the native AMPA-Rs that
were treated with glutamate and glutamate+CTZ, indi-
cating that lateral movement of the NTD dimers are
related to desensitization. The mandatory movement of
the NTD dimers was also predicted by the crystal
structure of the GluA2cryst.
Mechanism of Subunit Assembly of AMPA-Rs
The subunit composition of the AMPA-Rs including the
composition of the auxiliary subunits determine the
biophysical properties of the ion channel and also affect
the rules that govern receptor localization and trafficking
[27, 142–145]. The molecular variety of the native
AMPA-R complex is now known to be very complex
because of many auxiliary subunits, including stargazin/
TARPs, cornichon, and CKAMP44 [47]. The dynamic
changes of the AMPA-R localization and channel properties
Fig. 5 The relationship between the EM and crystal structure of
AMPA-R. a The cryo-negative stain EM structure (left) and the crystal
structure of tetrameric GluA2cryst (PDB:3KG2) are shown at the
same scale. Comparison of the two structures (as shown below in b
and c) suggests that the NTD–LBD linker is flexible (see text for
detail). The red arrows indicate the pivot points that locate the
positions of the linkers that connect the NTD and LBD. b The NTD
tetramer from the crystal structure of GluR2cryst (green) was placed
into the EM density map of the native AMPA-R shown in (a)
(represented here in mesh). Four different views are shown. The size
and shape of the NTD density in the EM map is consistent with the
dimer-of-dimers organization of the NTDs in the crystal structure of
GluA2cryst. However, in order to place the NTD crystal into the EM
density map, the crystal needs to be displaced and tilted along the
pivot axis shown in (a). c The crystal structure of GluR2cryst (green)
was placed into the EM density map of the native AMPA-R shown in
(a) (represented here in mesh). Four different views are shown. The
arrangements of the NTDs relative to the rest of the structure are the
main differences between the global domain arrangements between
the two structures. The images were produced using UCSF Chimera
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excitatory synapses and thus represent some underlying
molecular mechanisms for synaptic plasticity. Interestingly,
evidence suggests that the molecular composition of AMPA-
Rs can change in response to activity [98, 146, 147]. Recent
studies also suggest that glutamate and RNA editing
regulates the assembly process of AMPA-Rs [142, 148].
This indicates that subunit assembly is a new addition to
known mechanisms modulating AMPA-R function and
localization. Subunit assembly is an important process during
AMPA-R trafficking, but the molecular process remained
poorly characterized.
The trafficking pathway of AMPA-Rs consists of multiple
steps [28]( F i g .6). AMPA-Rs are synthesized as monomers
in the ER and inserted into the ER membrane where they
assemble into tetramers. The tetrameric AMPA-Rs continue
their journey from the ER to the Golgi and exit the trans-
Golgi network as part of trafficking vesicles. After reaching
the cell surface, AMPA-Rs interact with a variety of scaffold
proteins that facilitate synaptic localization of the receptors
[90, 149, 150]. AMPA-Rs are also recycled and move back
and forth between endosomes and the synapse [145, 151].
The ER is the site of synthesis of various membrane
proteins. The ER actively facilitates the folding of
membrane proteins and their exit from the ER in the form of
trafficking vesicles [152]. The folding process is assisted by
molecular chaperones including the members of the classical
Hsp 70, Hsp 40, and Hsp 90 protein families. The assembled
membrane proteins are incorporated into budding vesicles
that are coated with COPII coat protein and further exported
from the ER in trafficking vesicles [153–155]. When
unfolded or misfolded proteins accumulate in the ER, the
unfolded protein response (UPR) signals are triggered. For
example, the transmembrane transcription factor ATF6
mediates the UPR by upregulating ER-specific chaperones
including BiP and GRP94 [156]. UPR also attenuates
transcription by activating ER resident kinases PERK and
IRE1 [157]. Misfolded proteins in the ER are exported out of
the lumen by retrotranslocation, another mechanism down-
stream of UPR that reduces the erroneously folded proteins
in the ER [158].
As described earlier, the studies of mature receptors
suggest that tetrameric AMPA-Rs have a dimer-of-dimers
organization. In the primary structure of the AMPA-R
subunits, the NTD follows the signal peptide and thus is the
first domain that is synthesized in the ER. The NTDs of
AMPA-Rs are known to form stable dimers, and together
with the more recent studies on the crystal structures of the
Fig. 6 Biosynthesis, subunit assembly, and trafficking of AMPA-R.
Schematic of the trajectories of the AMPA-R biosynthesis, assembly,
and trafficking is shown. AMPA-Rs are synthesized and assembled in
the ER and exported to the Golgi apparatus. In the ER, stable dimers
of AMPA-R subunits are formed and transition into tetramers. In the
structure of dimeric wild-type subunits, the NTD and TMD form
dimers but the LBD is separated. In contrast, the NTD, LBD, and
TMD are all compactly dimerized in the GluR2L504Y mutant, which
transition into tetramers much less efficiently. The domain organiza-
tion seen in the structure of the wild-type dimer is critical for efficient
tetramerization. A small quantity of GluR2L504Y tetramers is formed
and reach the cell surface by an unknown mechanism. The majority of
GluR2L504Y is not complex mannose glycosylated, suggesting that it
did not receive modification in the Golgi apparatus. It is likely that
most GluR2L504Y cannot even exit the ER or reach the cis-Golgi.
Stargazin/TARPs are associated with the mature AMPA-Rs. Stargazin
preferentially forms a stable complex with GluR2 tetramers but not
with dimers. The cornichon and CKAMP44 assemble together with
AMPA-Rs but the timing and location in relation to the subunit
assembly pathway of AMPA-R subunits are unclear. In the synapse,
the C-termini of stargazin/TARP and CKAMP44 interact with the
synaptic scaffold proteins such as PSD-95 that belongs to the
membrane associated guanylate kinase (MAGUK) family
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NTDs is the first instructive step during the assembly of the
AMPA-Rs into dimer-of-dimers organization [71, 72, 159–
161]. The functional assembly of AMPA-Rs was examined
by measuring channel currents from chimeric constructs of
glutamate receptors generated by domain swapping between
AMPA-R and kainate receptor subunits [162]. It was
concluded that both the NTD and the TMD are important
for obtaining functional ion channels.
Biochemically, it has been observed that subunit dimers
exist in the detergent extracted lysates of the brain, cultured
neurons, and the HEK cells expressing the subunits [96,
163–165]. The structural identity of these dimers and their
relation to the mature assembled receptors were not clear.
The
35S labeling has shown that the half-life of AMPA-Rs
in the spinal cord neuron culture is 18 h [166]. The speed of
maturation in neurons differs between subunits. In a pulse
chase experiment, the maturation of GluA1 subunit was
around 12 h, whereas the only one third of GluA2 mature in
22 h [165]. A recent study used a drug-inducible expression
of GluA2 subunit in stable HEK cell lines to gain control
over the timing and subunit composition during AMPA-R
biosynthesis [23]. The receptor expression reached the
maximum at around 24 h post-induction. The majority of
the glycosylation happened during the period of 12–24 h
post-induction, indicating that the post-Golgi trafficking
and cell surface expression happens during this period. At
the time point of 12 h after induction, the majority of
GluA2 were dimers. The turnover rate of AMPA-Rs in
neurons and the maturation speed in HEK cells are in good
agreement. In addition, the AMPA-Rs expressed in HEK
cells are functional ion channels [40], and thus the
assembly mechanism of AMPA-Rs can be studied in both
neuronal and HEK cell systems.
Mutations that Affect ER Export of AMPA-Rs
Based on the crystal structure of the LBD [51], a series of
point mutants around the glutamate binding pocket of the
LBD of GluA2 subunit were examined to test if there is
correlation between the ability to induce ligand-dependent
conformational change of the LBD and the ER export of the
receptor [148, 167]. In fact, the mutations that reduced
glutamate affinity also impaired ER export, whereas a
mutant that facilitated ligand-induced conformational
change had an accelerated ER export. The AMPA-Rs are
not the first membrane receptor whose folding and ER
export are modulated by the ligands and co-factors. Among
the glutamate receptors, the kainate receptors were the first
that were reported to require the ability to bind to glutamate
in order to efficiently export from the ER [168–170].
Specifically, mutations in the LBD that block glutamate
binding in kainate receptors had deficits in ER export. More
recently, it was shown that the glycine binding to the
GluN1 subunit was critical for surface expression of the
NMDA-Rs [171]. Furthermore, the ER export of the δ
opioid receptor and rhodopsin improve in the presence of
membrane-permeable opioid ligands and vitamin A, re-
spectively [172, 173].
In mature AMPA-Rs, the glutamate-induced conforma-
tional changes initiate a series of events starting with the
closure of the clamshell-like structure of the LBD [51, 53].
Functionally, continuous exposure to glutamate results in
desensitization. In terms of protein conformation, desensi-
tization is caused by the destabilization of the LBD dimer
[52]. Increasing the affinity of the LBDs in the dimer
inhibits desensitization whereas reducing the affinity
facilitates desensitization [57, 174]. Interestingly, the
destabilization of the LBD dimers that follows clamshell
closure is also suggested to play critical roles in ER export
and receptor assembly [23, 148]. The non-desensitizing
point mutant GluR2 L504Y (also known as L483Y when
numbering the first amino acid immediately after the
cleavage site of the signal peptide) traffics to the cell
surface at reduced efficiency compared to the wild-type
[163]. Similarly in the kainate receptor subunit GluK2, a
mutation that blocks desensitization of the ion channel also
reduces its surface delivery [175]. The GluA2 L504Y and
analogous mutants in other AMPA-R subunits have been
studied extensively from the point of view of non-
desensitizing mutants [57, 127, 176, 177]. Blocking
desensitization in these point mutants has been correlated
with the inability of the LBD dimers to separate in the
crystal structures of S1S2 constructs [57].
It is not clear if the clamshell closure of the LBD is
required before or after the dimer-to-tetramer transition
[148]. When overexpressed in HEK cells, the mutant
GluK2 subunits that cannot bind glutamate were detected
as a mixture of monomer, dimer, tetramers, and high
molecular weight misfolded aggregates, the latter being
the majority [169]. In the case of GluA2 subunit, the
T686A and T686S mutations that are predicted to destabi-
lize the clamshell closure of the LBD did not exit ER but
the oligomeric state of the immature receptor trapped in the
ER was uncharacterized [148]. The non-desensitizing
GluA2 L504Y mutant expressed in HEK cells were
detected as mixture of monomer, dimer, tetramer, and high
molecular weight unfolded (or misfolded) aggregates [148].
On the other hand, the majority of GluA2 L504Yexisted as
dimers when expressed at a moderate level using stable cell
lines in which the expression levels of the subunit was
controlled by DOX, and thus by preventing UPR and
aggregates [23]. Clearly, GluA2 L504Y cannot transition
efficiently from dimer to tetramer. However, it remains to
be determined if the mutant GluA2 subunits that cannot
bind to glutamate can transition into tetramers under similar
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possibility is that glutamate may facilitate the dimer-to-
tetramer transition. Various evidence supports the idea that
in the brain, two homodimers of different subunits [such as
(GluA1)2 and (GluA2)2] combine and form heterotetrameric
AMPA-Rs [such as (GluA1)2(GluA2)2][ 39, 161, 162].
Because the subunit composition governs the characteristics
of individual AMPA-Rs, the molecular mechanism of the
dimer-to-tetramer transition is particularly important when
considering endogenous heterotetrameric AMPA-Rs.
The flip/flop alternatively spliced site also affects receptor
maturation. The flip and flop variants differ in their gating
properties [32] and the flip variant matures more efficiently
than the flop [148, 178]. Four out of nine residues that differ
between flip and flop variants are located in the alpha-helices
Ja n dKi nt h eL B D[ 51]. These helices are part of the
interface that mediates dimerization of the two LBDs. The
flip variant recovers from desensitization faster compared to
the flop variant [179]. The L758 in flop, or equivalently the
V758 in flip, were identified as the critical residue that
determines the characteristic kinetics during the recovery
from desensitization in each splice variant. Switching the
residue L758 in flop to V was sufficient to convert the
resensitization of flop into the flip phenotype, and vice versa.
The residue 758 also plays a key role in the maturation
phenotype [148]. If residue 758 is switched to V in GluA2
flop, the resulting GluA2 flop L758V mutant matures as
efficiently as the flip phenotype, and conversely. The
mutants that recover faster from desensitization also export
efficiently from the ER. This might imply that after being
used to facilitate subunit assembly, the release of glutamate
from the LBD may be another rate-determining step during
the assembly of the AMPA-Rs.
The R/G editing site is located immediately before the
flip/flop splice site in the LBDs of GluA2–4 subunits [35].
The G form desensitizes faster and recovers faster than the
R form [180, 181]. The crystal structure of the unedited
LBD with R743 proposed the possibility that the R743 may
stabilize the dimer interface [163]. However, compared to
the G form, the R form had a greater tendency to
tetramerize and mature, and thus stabilization of the LBD
interface is preferred for maturation.
The Q/R editing is located in the channel pore in the
cytoplasmic side that corresponds to the ion selectivity filter
in the potassium channels [35, 182]. The majority of the
endogenous GluA2 subunits are the R form, which confers
the AMPA-R calcium impermeable. Interestingly, the Q
form is more favorable than R form for homotetrameriza-
tion [164]. It has been suggested that the larger side group
of R compared to the more compact Q may interfere with
forming the narrow constriction in the 4-fold symmetric
channel pore [164]. This means that the mechanism that
determines the difference between the efficiency of matu-
ration of the Q/R forms is different from that of the flip/flop
and R/G variants. The Q/R editing site was also implicated
in the functional interaction with stargazin/TARPs [129],
and thus may have multiple functional roles. The R form of
GluA2 subunits homotetramerize inefficiently compared to
the Q, and this is proposed as a potential mechanism by
which the mature R form preferentially heterotetramerizes
with the Q forms of the other GluA subunits [142, 164].
Single Particle EM Study of the Dimer Intermediates
of AMPA-Rs
The dimeric biosyntheticAMPA-Rs werepurifiedandstudied
recently by single particle EM [23]. In this study, the authors
establish a simplified system in which they can study the
assembly of AMPA-Rs. Biosynthetic and trafficking inter-
mediates have a shorter lifetime compared to mature and
targeted proteins. Thus, biochemical enrichment is less
efficient, more laborious, and requires a larger quantity of
raw material. To overcome these hurdles, the GluA2 subunit
was DOX dependently expressed in HEK cells and purified
at an early time point in order to enrich for biosynthetic
intermediates. Importantly, the dimer population appeared
before the tetramers, indicating that the dimers are the stable
biosynthetic intermediates of AMPA-Rs.
As described earlier, GluA2 L504Y, the non-desensitizing
point mutant, has significantly decreased cell surface expres-
sion compared to the wild-type GluA2. Consistent with the
observed deficit in trafficking, GluA2 L504Y is deficient in
dimer-to-tetramer transition when expressed in HEK cells
using a DOX-dependent expression system [23]. Even after
24 h after inducing the expression, the majority of the GluA2
L504Y existed as dimers and did not have mature glycosyl-
ation, whereas at this time point the majority of the GluA2
wild-type are maturely glycosylated and formed tetramers.
Interestingly, the single particle EM structures of the GluA2
wild-type and GluA2 L504Y were significantly different
(Fig. 7a, b).
Fig. 7 Structures of the dimer intermediates and the subunit assembly
pathway of AMPA-R. a Top—the EM structure of dimer intermediate of
wild-type GluA2 is shown from two different views. Bottom—placement
of known crystal structures into the EM density map. Red, ligand binding
domain of GluA2 (PDB:3H5W); blue, ligand binding domain of GluR2
S1S2 wild-type (PDB:1FTJ). b Top—the EM structure of dimer
intermediate of GluA2 L504Y is shown from two different views.
Bottom—placement of known crystal structures into the EM density
map. Red, ligand binding domain of GluA2 (PDB:3H5W); blue,l i g a n d
binding domain of GluR2 S1S2 wild-type (PDB:1FTJ). c Proposed
AMPA-R subunit assembly pathways are shown. In the wild-type
subunit dimers, the LBDs are not dimerized. We propose that the LBD
dimers in wild-type subunits are formed during the dimer-to-tetramer
transition. On the other hand, the LBDs in the L504Y mutant subunits
form intra-dimer dimers that may prevent efficient dimer-to-tetramer
transition. NTD—red and orange, LBD—blue and purple, TMD—yellow
and green. The images were reproduced from [23]
b
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of the dimer intermediates of both GluA2 wild-type and
L504Y. A significant difference in the structures was
observed in the arrangements of the LBDs. Specifically,
the two LBDs were separated in the wild-type GluA2
dimers, whereas in the case of L504Y mutant they were
fused as a single density. Importantly, the difference in
molecular shapes is correlated with their contrasting ability
to transition from dimer to tetramer. The comparison of the
structures between the GluA2 dimers of wild-type and
Mol Neurobiol (2010) 42:161–184 177L504Y suggests that the separation of the LBD is required
for efficient dimer-to-tetramer transition.
The isolated NTDs of GluA2 form stable dimers [71, 72,
159–161], and both the NTD and the TMD are necessary to
form functional ion channels of GluA2 [162]. Accordingly,
the NTDs and the TMDs were dimerized in the dimeric
GluA2 wild-type, providing structural evidence for previ-
ously reported observations. The compact structure of the
LBDs in the dimeric GluR2L504Y agrees with the high
affinity dimer formed by the S1S2 construct of the isolated
LBD that carries the same mutation [57]. The structure is
also consistent with previous results indicating that native
tetrameric AMPA-Rs treated with 1 mM glutamate have
more compact structures in the presence of cyclothiazide,
an inhibitor of desensitization [66].
The two LBDs are separated in the GluR2 wild-type
dimers and, therefore, intermolecular dimerization of the
LBDs can potentially occur during the assembly of a
tetramer between two GluR2 wild-type dimers. In contrast,
the LBDs are fused in the GluR2 L504Y dimers. Since this
mutation causes a defect in dimer-to-tetramer transition, it
is conceivable that the separation of LBD dimers is required
to drive the formation of tetramers. These results support a
new model for the subunit assembly pathway of AMPA-Rs
in which the dimer-to-tetramer transition accompanies
formation of two new LBD dimers between the two
molecular dimers of subunits (Fig. 7c). This suggests a
domain arrangement in the tetrameric AMPA-Rs in which
the NTD and the LBD of each subunit forms a dimer with a
different neighboring subunit. Importantly, a similar con-
nection between domains in the AMPA-R was also
observed in GluA2cryst tetramer despite that linker
sequences connecting the NTD and LBD were significantly
engineered in their construct [75], indicating that the inter-
domain contacts play stronger roles in defining the global
domain arrangements of the tetrameric AMPA-Rs. The
chronological order of the inter-domain contacts during the
subunit assembly process may also govern the global domain
arrangements of the assembled receptor.
The global domain arrangements in the dimer intermedi-
ates and the proposed assembly pathway to the mature
tetramericGluA2provide new interpretationsto theprevious
studies of the mutant GluA2 with maturation deficits. When
considering the variants produced by the RNA editing of the
R/G site, the stronger interaction between the LBDs
observed in the R variant may be advantageous over the Q
variant during the dimer-to-tetramer transition when dimers
are formed between the LBDs of two distinct dimer
intermediates of subunits. On the other hand, the premature
stabilization of the intra molecular LBD dimer within the
subunit dimer intermediate will prevent the inter molecular
LBD dimerization that should take place during the dimer-
to-tetramer transition. Such a mechanism may explain why
too strong of interactions between the LBDs, such as seen
in the L504Y mutant, are unfavorable for the dimer-to-
tetramer transition, but moderate interaction is preferred for
maturation. Consistently, slowing the desensitization by
introducing GluA2 L504A (equivalent to L483A) mutation
accelerates ER export and tetramerization [148]. The
mechanism by which the GluA2 L504A slows desensitiza-
tion is by stabilizing the LBD dimer interface but not to the
extent of the GluA2 L504Y mutant [174]. Furthermore,
continuous application of competitive antagonist NBQX in
culture rescued surface expression of the analogous L504Y
mutation in GluA4 subunit [167]. These observations
support the idea that optimal and reversible stabilization
of the LBD dimer interface facilitates AMPA-R maturation
[148]. A mutation that slows desensitization, however, does
not necessarily correlate with efficient maturation under the
same genetic background. An example of such exception is
when GluA2 flip wild-type and GluA2flop L758V were
compared, despite that the former desensitize at a slower
rate than the latter, both mature at a similar rate [148]. It is
proposed that the requirement to bind to glutamate for ER
exit is a mechanism to ensure that only functional receptors
reach the cell surface [168]. By only allowing receptors that
are capable of destabilizing the LBD dimer interface may
prevent receptors deficient in desensitization from reaching
the cell surface [148].
An important remaining question is whether it is
possible to extend what we learned from the homotetra-
meric AMPA-Rs to understanding the assembly mechanism
of the heterotetrameric receptors. A quantitative mass
spectrometry experiment estimates that in the PSD fraction
of hippocampus, the total molecular copies of GluA2 is
approximately the same as the sum of GluA1 and GluA3
[183]. The AMPA-Rs made by homotetrameric subunits
have the voltage-dependent rectifying property [184].
Because the majority of the AMPA-R-mediated currents
in neurons do not have this characteristic, AMPA-Rs on the
neuronal surface are likely to be mostly heterotetrameric
receptors [39, 185]. Why are homotetrameric AMPA-R not
assembled and trafficked to the synapses? Since calcium-
permeable AMPA-Rs exist in the nervous system, regula-
tion of subunit assembly by the Q/R editing site of GluA2
may not explain all cases. What are the mechanisms
involved in switching of the subtypes of AMPA-Rs?
Understanding the molecular mechanism of the AMPA-R
assembly will contribute to answering these questions.
The assembly process of AMPA-Rs is also related to
diseases. In humans, the GRIK3 (GluA3) G833R mutant is
among one of the mutations that was found in patients
diagnosed as X-linked mental retardation [14]. AMPA-Rs
that carry the G833R mutation are misfolded and the
channel function is also impaired. Can neurological and
psychiatric disorders caused by protein misfolding be
178 Mol Neurobiol (2010) 42:161–184treated? Possibly, yes. For example, a point mutation in the
photoreceptor that results in misfolding is a cause of retinal
neurodegenerative disorder known as rod photoreceptor
degeneration and autosomal dominant retinitis pigmentosa
[186, 187]. The accumulation of the misfolded photorecep-
tor in the ER induces UPR and other cellular pathology that
ultimately leads to neuronal cell death. Interestingly, in a
mouse disease model that carries the mutation, the
phenotype can be rescued by overexpressing ER chaperone
BiP [188], providing an example of genetic manipulation of
the UPR to cure the disease phenotype. In this view, precise
understanding of the mechanism of AMPA-R assembly
may contribute to determining intervening methods that can
treat patients who are affected by X-linked mental
retardation.
Contribution of the AMPA-R Auxiliary Subunits
on Receptor Assembly
The cascade of conformational changes of the LBD is
utilized by the mature AMPA-Rs during channel gating and
by the immature AMPA-Rs during maturation (ER export
and assembly), as discussed in the previous section. The
known auxiliary subunits (stargazin/TARPs, cornichon 2/3,
and CKAMP44) can modulate channel gating. The modu-
lation of gating often results from the modulation of
conformational changes associated with gating. In this
view, if an auxiliary subunit associates with AMPA-Rs
during the assembly process, it may also influence the
maturation of the receptor.
A chaperone-like function for the auxiliary subunits was
first proposed for stargazin [189]. Both AMPA-Rs and
stargazin are transmembrane proteins, raising the possibility
that AMPA-R and stargazin may potentially interact as
early as when they are synthesized in the ER. In addition,
because stargazin facilitates AMPA-R trafficking, there is
also a possibility that stargazin can promote AMPA-R
biogenesis by functioning as a molecular chaperone. In fact,
stargazin, AMPA-Rs, and stress response chaperone BiP
co-localize in the ER, suggesting a possible role of
stargazin in assisting AMPA-R folding under stress con-
ditions [189]. On the other hand, AMPA-Rs can fold
properly in the absence of stargazin/TARPs in HEK cells
without stargazin [23], indicating that stargazin is not
necessary for the folding of AMPA-Rs. Consistently,
stargazin/TARPs form a stable complex with GluR2
tetramers but not with the dimer intermediates during
biogenesis. In addition, the time course of expression of
the newly synthesized GluR2 was not affected by the
presence of stargazin in these cell lines.
The precise function of cornichons in neurons remains
elusive. In HEK cells, cornichon 2 increases surface
expression of the AMPA-Rs and also modulates channel
gating [45]. However, currently it is controversial whether
cornichons have similar functions in the neuronal synapse
[190]. Two reports demonstrate a biochemical interaction
between cornichon and AMPA-Rs from brain, and corni-
chons can modulate channel function when co-expressed
with AMPA-Rs in HEK cells. In yeast and Drosophila,
cornichon homologues play critical roles in trafficking and
secretion [191, 192].
The recent study characterizing the roles of cornichons
in AMPA-R function suggests that in neurons cornichons
may play roles as molecular chaperones [190]. The
distribution of the cornichons according to mRNA locali-
zation in the Allen Brain Atlas indicates the presence of all
homologues throughout the brain, with particularly high
levels in the hippocampus [193]. This may suggest a greater
need for the AMPA-R chaperone function in spatially
restricted areas such as the hippocampus where there are
higher demands to traffic AMPA-Rs. More studies are
needed to precisely determine the function of cornichon 2
and 3 in the brain.
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